• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者在一年随访期间新冠后疲劳的患病率及相关危险因素

Prevalence and associated risk factors of post COVID fatigue among Parkinson's disease patients during one year follow up.

作者信息

Yang Chenlu, Guo Dandan, Zhu Yugang, Tian Min, Zhang Bohan, Yang Yang, Yang Qingchao, Liu Yiming

机构信息

Department of Neurology, Qilu Hospital of Shandong University, Jinan, Shandong, China.

出版信息

Sci Rep. 2024 Dec 30;14(1):31966. doi: 10.1038/s41598-024-83567-1.

DOI:10.1038/s41598-024-83567-1
PMID:39738701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11685509/
Abstract

One of the most common post-COVID-19 condition is persistent fatigue, while post-COVID fatigue among Parkinson's disease (PD) patients is less known. This study was aimed to investigate the prevalence and risk factors of post-COVID fatigue in PD patients at 1 month and 12 months after symptom onset. PD patients attending clinic from December 2022 to January 2023 were enrolled consecutively in the study. All participants were assessed demographics, details of COVID-19 infection, clinical characteristics as well as fatigue status with Fatigue Severity Scale (FSS) (cutoff ≥ 36) at 1-month and 12-month after symptom onset. Univariate and multivariate Logistic regression analysis were used to evaluate the risk factors of post-COVID fatigue. Fatigue symptoms were reported by 75.89% of PD patients and associated with decreased physical activity and number of initial symptoms of COVID-19 at 1 month. Meanwhile, 32.99% of PD patients at 12 months reported persistent fatigue. Using of antiviral drugs, decreased physical activity, anxiety status and delayed ON were associated with persistent fatigue at 12 months. Clinically persistent fatigue was pervasive in our study at 12-month after COVID infection. These findings implicate using of antiviral drugs, decreased physical activity, anxiety status and delayed ON were possible predictors of post-COVID persistent fatigue.

摘要

新型冠状病毒肺炎(COVID-19)后最常见的状况之一是持续性疲劳,而帕金森病(PD)患者的COVID-19后疲劳情况鲜为人知。本研究旨在调查PD患者在症状出现后1个月和12个月时COVID-19后疲劳的患病率及危险因素。2022年12月至2023年1月到门诊就诊的PD患者连续纳入本研究。所有参与者在症状出现后1个月和12个月时接受人口统计学评估、COVID-19感染细节、临床特征以及使用疲劳严重程度量表(FSS)(临界值≥36)评估疲劳状态。采用单因素和多因素Logistic回归分析评估COVID-19后疲劳的危险因素。75.89%的PD患者报告有疲劳症状,且在1个月时与身体活动减少及COVID-19初始症状数量有关。同时,12个月时32.99%的PD患者报告有持续性疲劳。使用抗病毒药物、身体活动减少、焦虑状态和“开”期延迟与12个月时的持续性疲劳有关。在我们的研究中,COVID感染后12个月时临床上持续性疲劳很普遍。这些发现表明,使用抗病毒药物、身体活动减少、焦虑状态和“开”期延迟可能是COVID-19后持续性疲劳的预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e94/11685509/c0360d6a5956/41598_2024_83567_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e94/11685509/c0360d6a5956/41598_2024_83567_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e94/11685509/c0360d6a5956/41598_2024_83567_Fig1_HTML.jpg

相似文献

1
Prevalence and associated risk factors of post COVID fatigue among Parkinson's disease patients during one year follow up.帕金森病患者在一年随访期间新冠后疲劳的患病率及相关危险因素
Sci Rep. 2024 Dec 30;14(1):31966. doi: 10.1038/s41598-024-83567-1.
2
The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study.在 SARS-CoV-2 感染中发病时存在头痛与新冠后长期头痛和疲劳相关:一项病例对照研究。
Cephalalgia. 2021 Nov;41(13):1332-1341. doi: 10.1177/03331024211020404. Epub 2021 Jun 16.
3
Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study.新冠病毒感染后急性后遗症/新冠后综合征成年患者在急性感染后第二年的持续症状及临床发现:一项基于人群的巢式病例对照研究
PLoS Med. 2025 Jan 23;22(1):e1004511. doi: 10.1371/journal.pmed.1004511. eCollection 2025 Jan.
4
Age differences in prevalence and symptoms of post-COVID-19 condition among children: a prospective cohort study.儿童新冠后状况的患病率和症状的年龄差异:一项前瞻性队列研究
Eur J Pediatr. 2025 Mar 5;184(3):228. doi: 10.1007/s00431-025-06064-1.
5
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.新冠肺炎出院患者 6 个月的后果:一项队列研究。
Lancet. 2021 Jan 16;397(10270):220-232. doi: 10.1016/S0140-6736(20)32656-8. Epub 2021 Jan 8.
6
Changes in fatigue of Parkinson's disease during the recurrent COVID-19 pandemic: Findings from the longitudinal analysis of the PHASE study.复发性新冠疫情期间帕金森病疲劳的变化:PHASE研究的纵向分析结果
Parkinsonism Relat Disord. 2024 Dec;129:107161. doi: 10.1016/j.parkreldis.2024.107161. Epub 2024 Oct 5.
7
Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up.COVID-19 后急性综合征(PACS)在出院后的流行情况及其预测因素:一项中位随访 4 个月的队列研究。
PLoS One. 2021 Dec 7;16(12):e0260568. doi: 10.1371/journal.pone.0260568. eCollection 2021.
8
Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.不同随访期的新冠后综合征症状的流行率:系统评价和荟萃分析。
Clin Microbiol Infect. 2022 May;28(5):657-666. doi: 10.1016/j.cmi.2022.01.014. Epub 2022 Feb 3.
9
Short and long-term trajectories of the post COVID-19 condition: Results from the EuCARE POSTCOVID study.新冠后状况的短期和长期轨迹:EuCARE POSTCOVID研究结果
BMC Infect Dis. 2025 Apr 29;25(1):625. doi: 10.1186/s12879-025-10805-w.
10
Three-Month Follow-Up of the Post-COVID Syndrome after Admission to a Specialised Post-COVID Centre-A Prospective Study Focusing on Mental Health with Patient Reported Outcome Measures (PROMs).COVID-19 后综合征患者入住专科 COVID-19 后中心 3 个月随访:一项关注心理健康的前瞻性研究,采用患者报告结局测量(PROMs)。
Int J Environ Res Public Health. 2024 Aug 16;21(8):1076. doi: 10.3390/ijerph21081076.

本文引用的文献

1
Clinical features and predictive nomogram for fatigue sequelae in non-severe patients infected with SARS-CoV-2 Omicron variant in Shanghai, China.中国上海感染新冠病毒奥密克戎变异株的非重症患者疲劳后遗症的临床特征及预测列线图
Brain Behav Immun Health. 2024 Oct 18;42:100889. doi: 10.1016/j.bbih.2024.100889. eCollection 2024 Dec.
2
The Impact of Fatigue on Sleep and Other Non-Motor Symptoms in Parkinson's Disease.疲劳对帕金森病睡眠及其他非运动症状的影响。
Brain Sci. 2024 Apr 19;14(4):397. doi: 10.3390/brainsci14040397.
3
Association between fatigue and MDS-UPDRS in individuals with Parkinson's disease: cross-sectional study.
帕金森病患者的疲劳与 MDS-UPDRS 之间的关联:横断面研究。
Neurol Sci. 2024 Sep;45(9):4309-4321. doi: 10.1007/s10072-024-07466-z. Epub 2024 Mar 26.
4
SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: systematic review with frequentist and Bayesian meta-analyses.SARS-CoV-2 易感性以及伴有神经退行性疾病的 COVID-19 患者的疾病过程和结局:系统评价与频率派和贝叶斯荟萃分析。
Br J Psychiatry. 2023 Aug;223(2):348-361. doi: 10.1192/bjp.2023.43.
5
Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19.神经炎症中的多巴胺传递失衡:对长期 COVID-19 的观察。
Int J Mol Sci. 2023 Mar 15;24(6):5618. doi: 10.3390/ijms24065618.
6
Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease.帕金森病中左旋多巴转运和吸收的胃肠道屏障
Eur J Neurol. 2023 May;30(5):1465-1480. doi: 10.1111/ene.15734. Epub 2023 Mar 7.
7
Long COVID: major findings, mechanisms and recommendations.长新冠:主要发现、机制和建议。
Nat Rev Microbiol. 2023 Mar;21(3):133-146. doi: 10.1038/s41579-022-00846-2. Epub 2023 Jan 13.
8
Long-term outcomes in COVID-19 patients who recovered from the first wave of the pandemic.在第一波疫情中康复的新冠病毒疾病患者的长期预后。
Natl Sci Rev. 2022 Sep 20;9(11):nwac192. doi: 10.1093/nsr/nwac192. eCollection 2022 Nov.
9
The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis.住院和非住院人群中“长新冠”的患病率及长期健康影响:一项系统评价与荟萃分析
EClinicalMedicine. 2022 Dec 1;55:101762. doi: 10.1016/j.eclinm.2022.101762. eCollection 2023 Jan.
10
Fatigue, sleep quality and mental health symptoms in Brazilian women during the COVID-19 pandemic: longitudinal study.巴西女性在 COVID-19 大流行期间的疲劳、睡眠质量和心理健康症状:纵向研究。
Sci Rep. 2022 Nov 27;12(1):20346. doi: 10.1038/s41598-022-23612-z.